Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 217

The DOI matches its Crossref record.

The role of natural killer cells in human disease

Whiteside, Theresa L., Herberman, Ronald B.·1989·Clinical Immunology and Immunopathology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/0090-1229(89)90096-2

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 153

  1. Abo, 1984, Characterization of human granular lymphocyte subpopulations expressing NHK-1 (Leu-7 and Leu-11) antigens in the blood and lymphoid tissues from fetuses, neonates and adults, Eur. J. Immunol., 1, 616, 10.1002/eji.1830140707 · DOI
  2. Adler, 1988, Interleukin-2 induction of lymphokine-activated killer acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission, Blood, 71, 709, 10.1182/blood.V71.3.709.709 · DOI
  3. Agostini, 1985, Phenotypical and functional analysis of natural killer cells in sarcoidosis, Clin. Immunol. Immunopathol., 37, 262, 10.1016/0090-1229(85)90158-8 · doi:10.1016/0090-1229(85)90158-8
  4. Alcocer-Varela, 1982, Decreased production of and response to interleukin 2 by cultured lymphocytes from patients with systemic lupus erythematosus, J. Clin. Invest., 69, 1388, 10.1172/JCI110579 · DOI · Paper page
  5. Aoki, 1987, Low NK syndrome (LNKS): Clinical and immunologic features, Nat. Immun. Cell Growth Regul., 6, 116
  6. Balch, 1983, Depressed levels of granular lymphocytes with natural killer (NK) cell function in 247 cancer patients, Ann. Surg., 198, 192, 10.1097/00000658-198308000-00014 · DOI
  7. Barlozzari, 1983, In vivo role of natural killer cells: Involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats, J. Immunol., 131, 1024, 10.4049/jimmunol.131.2.1024 · DOI · Paper page
  8. Bast, 1984, Immunologic approaches to the management of ovarian carcinoma, Semin. Oncol., 11, 264
  9. Baumann, 1986, Correlation of circulating natural killer cell count with prognosis in large cell lymphoma, Cancer, 57, 2309, 10.1002/1097-0142(19860615)57:12<2309::AID-CNCR2820571212>3.0.CO;2-H · doi:10.1002/1097-0142(19860615)57:12<2309::aid-cncr2820571212>3.0.co;2-h
  10. Benczur, 1980, Dysfunction of natural killer cells in multiple sclerosis: A possible pathogenetic factor, Clin. Exp. Immunol., 39, 657
  11. Biron, 1982, Activation and role of natural killer cells in virus infections, Med. Microbiol. Immunol., 170, 155, 10.1007/BF02298196 · doi:10.1007/bf02298196
  12. Biron, 1983, Increase in NK cell number and turnover rate during acute viral infections, J. Immunol., 131, 1539, 10.4049/jimmunol.131.3.1539 · DOI
  13. Biron, 1988, Susceptibility to viral infections in an individual with a complete lack of natural killer cells, Nat. Immun. Cell Growth Regul., 7, 47
  14. Blomgren, 1980, Natural killer activity in peripheral lymphocyte population following local radiation therapy, Acta Radiol. Oncol., 19, 139, 10.3109/02841868009130145 · DOI
  15. Bonavida, 1986, Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger of NK cells for NKCF production by target cells, and partial restoration by IL-2, J. Immunol., 137, 1157, 10.4049/jimmunol.137.4.1157 · DOI
  16. Borysiewicz, 1985, Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: Demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells, J. Immunol., 134, 2695, 10.4049/jimmunol.134.4.2695 · DOI
  17. Bowden, 1987, Natural cytotoxic activity against cytomegalovirus-infected target cells following marrow transplantation, Transplantation, 44, 504, 10.1097/00007890-198710000-00009 · DOI
  18. Brenner, 1987, Human large granular lymphocytes induce immunoglobulin synthesis after bone marrow transplantation, Eur. J. Immunol., 17, 43, 10.1002/eji.1830170108 · DOI
  19. Bukowski, 1983, Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo, J. Immunol., 131, 1531, 10.4049/jimmunol.131.3.1531 · DOI · Paper page
  20. Caliguiri, 1987, Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome, J. Immunol., 139, 3306, 10.4049/jimmunol.139.10.3306 · DOI · Paper page
  21. Chan, 1986, Heterogeneity of large granular lymphocyte proliferations: Delineation of two major subtypes, Blood, 68, 1142, 10.1182/blood.V68.5.1142.1142 · DOI
  22. Choe, 1987, natural killer cell activity of prostatic cancer patients, Cancer Invest., 5, 285, 10.1080/07357908709170101 · doi:10.1080/07357908709170101
  23. Cortesina, 1988, Treatment of recurrent squamous cell carcinoma of head and neck with low doses of interleukin-2 (IL2) injected perilymphatically, Cancer, 62, 2482, 10.1002/1097-0142(19881215)62:12<2482::AID-CNCR2820621205>3.0.CO;2-9 · doi:10.1002/1097-0142(19881215)62:12<2482::aid-cncr2820621205>3.0.co;2-9
  24. Cunningham-Rundles, 1981, Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women, JNCI, 67, 585
  25. Cuturi, M. C., Anegon, I., Sherman, F., Loudon, R., Clark, S. C., Perussia, B., and Trinchieri, G., Production of hematopoietic colony-stimulating factors by human natural killer cells. J. Exp. Med., in press.
  26. del Prete, 1986, Cytolytic T lymphocytes with natural killer activity in thyroid infiltrate of patients with Hashimoto's thyroiditis: Analysis at clonal level, J. Clin. Endocrinol. Metab., 62, 52, 10.1210/jcem-62-1-52 · doi:10.1210/jcem-62-1-52
  27. Dickenson, 1985, Natural killer cell activity in childhood acute lymphoblastic leukemia in remission, Brit. J. Haematol., 59, 45, 10.1111/j.1365-2141.1985.tb02962.x · DOI
  28. Eby, 1988, Natural killer cell activity as a marker of immune dysfunction in the chronic fatigue syndrome, Nat. Immun. Cell Growth Regul., 7, 48
  29. Edelman, 1989, AIDS: A syndrome of immune dysregulation, dysfunction and deficiency, FASEB J., 3, 22, 10.1096/fasebj.3.1.2562947 · DOI
  30. Egan, 1983, Natural killer cells in systemic lupus erythematosus: Abnormal numbers and functional immaturity of HNK1+ cells, Arthritis Rheum., 26, 623, 10.1002/art.1780260508 · doi:10.1002/art.1780260508
  31. Fauci, 1988, The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis, Science, 239, 617, 10.1126/science.3277274 · DOI · Paper page
  32. Fitzgerald, 1985, Human natural killer cells limit replication of herpes simplex virus type 1 in vitro, J. Immunol., 134, 2666, 10.4049/jimmunol.134.4.2666 · DOI
  33. Fox, 1986, Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patient with Sjogren's syndrome, J. Immunol., 137, 3162, 10.4049/jimmunol.137.10.3162 · doi:10.4049/jimmunol.137.10.3162
  34. Frizzera, 1981, Polymorphic diffuse B-cell hyperplasia in lymphomas in renal transplant recipients, Cancer Res., 41, 4262
  35. Froelich, 1989, Deficient interleukin-2 activated killer cell cytotoxicity in patients with systemic lupus erythematosus, Clin. Immunol. Immunopathol., 50, 132, 10.1016/0090-1229(89)90228-6 · doi:10.1016/0090-1229(89)90228-6
  36. Frydecka, 1986, Early effects of radiotherapy on natural killer activity in patients with gynecological malignancies, Folia Haematol., 113, 499
  37. Fujimori, 1987, Effect of lymphokine-activated killer cell fraction on the development of human hematopoietic progenitor cells, Cancer Res., 48, 534
  38. Gaspar, 1988, Role of interleukin 2 in inducing normalization of natural killer activity in systemic lupus erythematosus, Clin. Immunol. Immunopathol., 49, 204, 10.1016/0090-1229(88)90110-9 · doi:10.1016/0090-1229(88)90110-9
  39. Gatti, 1987, Circadian changes in human natural killer-cell activity, Prog. Clin. Biol. Res. A, 227, 399
  40. Ginsburg, 1983, Impaired natural killer cell activity in patients with inflammatory bowel disease: Evidence for a qualitative defect, Gastroenterology, 85, 846, 10.1016/0016-5085(83)90434-1 · DOI
  41. Gonzalez-Amaro, 1984, Natural killer cell-mediated activity in mixed connective tissue disease and its response to induction by interleukin 2, J. Clin. Immunoo., 4, 273, 10.1007/BF00915294 · doi:10.1007/bf00915294
  42. Gonzales-Amaro, 1987, Natural killer cell activity in dermatomyositis-polymyositis, J. Rheumatol., 14, 307
  43. Gorelik, 1982, Role of NK cells in the control of metastatic spread and growth of tumor cells in mice, Int. J. Cancer, 30, 107, 10.1002/ijc.2910300118 · DOI · Paper page
  44. Goss, 1985, Effect of natural killer cells on syngeneic bone marrow: In vitro and in vivo studies demonstrating graft failure due to NK cells in an identical twin treated by bone marrow transplantation, Blood, 66, 1043, 10.1182/blood.V66.5.1043.1043 · DOI
  45. Haliotis, 1980, Chediak-Higashi gene in humans. I. Impairment of natural killer function, J. Exp. Med., 151, 1029, 10.1084/jem.151.5.1039 · DOI
  46. Hanna, 1982, Role of natural killer cell in control of cancer metastasis, Cancer Metastasis Rev., 1, 45, 10.1007/BF00049480 · DOI · Paper page
  47. Hanto, 1985, Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation, Transplantation, 39, 461, 10.1097/00007890-198505000-00001 · doi:10.1097/00007890-198505000-00001
  48. Harris, 1976, The effect of immunosuppressive chemotherapy on immune function in patients with malignant disease, Cancer, 37, 1058, 10.1002/1097-0142(197602)37:2+<1058::AID-CNCR2820370813>3.0.CO;2-O · doi:10.1002/1097-0142(197602)37:2+<1058::aid-cncr2820370813>3.0.co;2-o
  49. Hayward, 1986, Cellular interactions in the lysis of varicellazoster virus infected human fibroblasts, Clin. Exp. Immunol., 63, 141
  50. Henderson, 1980, Cancer of the breast: The past decade, N. Engl. J. Med., 30, 302
  51. Herberman, 1979, Augmentation by interferon of human natural and antibody dependent cell-mediated cytotoxicity, Nature (London), 277, 221, 10.1038/277221a0 · DOI · Paper page
  52. Herberman, 1981, Natural killer cells, their role in defense against disease, Science, 214, 24, 10.1126/science.7025208 · DOI · Paper page
  53. Herberman, 1987, Lymphokine-activated killer cell activity: Characteristics of effector cells and their progenitors in blood and spleen, Immunol. Today, 8, 178, 10.1016/0167-5699(87)90035-1 · doi:10.1016/0167-5699(87)90035-1
  54. Hercend, 1986, Characterization of natural killer cells with anti-leukemia activity following allogeneic bone marrow transplantation, Blood, 67, 722, 10.1182/blood.V67.3.722.722 · DOI
  55. Hercend, 1988, Characteristics and uses of natural killer cells, Immunol. Today, 9, 291, 10.1016/0167-5699(88)91317-5 · DOI · Paper page
  56. Herman, 1985, Defective interleukin-1 production by natural killer cells of patients with cancer, Cancer Immunol. Immunother., 19, 148, 10.1007/BF00199724 · doi:10.1007/bf00199724
  57. Herrmann, 1987, In vitro regulation of human hematopoiesis by natural killer cells: Analysis at a clonal level, Blood, 69, 246, 10.1182/blood.V69.1.246.246 · DOI
  58. Hersey, 1979, Low natural killer-cell activity in familial melanoma patients and their relatives, Brit. J. Cancer, 40, 113, 10.1038/bjc.1979.147 · DOI
  59. Hirai, 1986, Natural killer (NK) cell activity and its in vitro response to interferon-alpha in chronic liver diseases and hepatocellular carcinoma, Liver, 6, 212, 10.1111/j.1600-0676.1986.tb01068.x · doi:10.1111/j.1600-0676.1986.tb01068.x
  60. Hirofuji, 1987, Natural killer inactivated killer activities in chronic liver disease and hepatocellular carcinoma: Evidence for a decreased lymphokine-induced activity of effector cells, Clin. Exp. Immunol., 68, 348
  61. Ho, 1988, The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestation s in children, Transplantation, 45, 719, 10.1097/00007890-198804000-00011 · doi:10.1097/00007890-198804000-00011
  62. Hoffman, 1980, Natural killer function in systemic lupus erythematosus, Arthritis Rheum., 23, 30, 10.1002/art.1780230106 · DOI
  63. Hokland, 1988, Natural killer function following allogeneic bone marrow transplantation: Very early reemergence but strong dependence of cytomegalovirus infection, Transplantation, 45, 1080, 10.1097/00007890-198806000-00016 · DOI
  64. Holmberg, 1984, The effect of natural killer cells on the development of syngeneic hematopoietic progenitors, J. Immunol., 133, 2933, 10.4049/jimmunol.133.6.2933 · DOI
  65. Holmes, 1988, Chronic fatigue syndrome: A working case definition, Ann. Int. Med., 108, 387, 10.7326/0003-4819-108-3-387 · DOI · Paper page
  66. Hussain, 1987, Evidence that the reduced numbers of natural killer cells in Type 1 (insulin-dependent) diabetes may be genetically determined, Diabetologica, 30, 907, 10.1007/BF00295872 · DOI
  67. Introna, 1983, Natural killer cells in human solid tumors, Cancer Metastasis Rev., 2, 337, 10.1007/BF00048566 · doi:10.1007/bf00048566
  68. Jondal, 1987, The human NK cell: A short overview and a hypothesis on NK recognition, Clin. Exp. Immunol., 70, 255
  69. Jones, 1985, Evidence for active Epstein-Barr virus infection in patients with persistent unexplained illnesses: Elevated anti-early antigen antibodies, Ann. Int. Med., 102, 127, 10.7326/0003-4819-102-1- · DOI · Paper page
  70. Kasahara, 1983, Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: Interleukin 2, interferon, and colony stimulating factor, J. Immunol., 131, 2379, 10.4049/jimmunol.131.5.2379 · DOI
  71. Katz, 1987, Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity, J. Immunol., 139, 55, 10.4049/jimmunol.139.1.55 · doi:10.4049/jimmunol.139.1.55
  72. Katz, 1982, Abnormal natural killer cell activity in systemic lupus erythematosus: An intrinsic defect in the lytic event, J. Immunol., 129, 1966, 10.4049/jimmunol.129.5.1966 · doi:10.4049/jimmunol.129.5.1966
  73. Kay, 1984, Impaired natural killer (NK) activity in patients with chronic lymphocytic leukemia is associated with a deficiency of azurophilic cytoplasmic granules in putative NK cells, Blood, 63, 305, 10.1182/blood.V63.2.305.305 · doi:10.1182/blood.v63.2.305.305
  74. Kay, 1986, Natural killer cells, CRC Crit. Rev. Clin. Lab. Sci., 22, 343
  75. Kedar, 1988, Therapy of advanced solid tumors in mice using chemotherapy in combination with interleukin 2 with and without lymphokine-activated killer cells, Israel J. Med. Sci., 24, 494
  76. Kohl, 1986, The genetic deficiency of leukocyte surface glycoprotein Mac-1, LFA-1, p150, 95 in humans is associated with defective antibody-dependent cellular cytotoxicity in vitro and defective protection against herpes simplex infection in vivo, J. Immunol., 137, 1688, 10.4049/jimmunol.137.5.1688 · doi:10.4049/jimmunol.137.5.1688
  77. Lanier, 1983, Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens, J. Immunol., 131, 1789, 10.4049/jimmunol.131.4.1789 · DOI · Paper page
  78. Levy, 1985, Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters, Health Psychol., 4, 99, 10.1037/0278-6133.4.2.99 · doi:10.1037/0278-6133.4.2.99 · Paper page
  79. Levy, 1987, Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer, J. Clin. Oncol., 5, 348, 10.1200/JCO.1987.5.3.348 · DOI · Paper page
  80. Levy, S., Herberman, R., Simons, A., Whiteside, T., Lee, J., McDonald, R., and Beadle, M., Persistently low natural killer cell activity: Immunological, hormonal, and psychological correlates. Nat. Immun. Cell Growth Regul., in press.
  81. Lin, 1987, Natural killer cell activity in lung cancer patients, Chest, 92, 1022, 10.1378/chest.92.6.1022 · doi:10.1378/chest.92.6.1022
  82. Liashenko, 1986, Functional activity of natural killers in viral hepatitis, A. Ter. Arhh., 58, 60
  83. Long, 1988, Lymphokine-activated killer cell purging of leukemia cells from bone marrow prior to syngeneic transplantation, Transplantation, 46, 433, 10.1097/00007890-198809000-00020 · doi:10.1097/00007890-198809000-00020
  84. Lopez, 1982, Studies of the cell lineage of the effector cells that spontaneously lyse HSV-1 infected fibroblasts (NK {HSV-1}), J. Immunol., 129, 824, 10.4049/jimmunol.129.2.824 · DOI
  85. Lopez, 1983, Severe acquired immune deficiency syndrome in male homosexuals: Diminished capacity to make interferon alpha in vitro associated with severe opportunistic infections, J. Infect. Dis., 148, 962, 10.1093/infdis/148.6.962 · DOI
  86. Lotz, 1986, Release of lymphokines after Epstein-Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans, J. Immunol., 136, 3636, 10.4049/jimmunol.136.10.3636 · doi:10.4049/jimmunol.136.10.3636
  87. Lotzova, 1987, Induction of NK cell activity against fresh leukemia in culture with interleukin 2, J. Immunol., 138, 718, 10.4049/jimmunol.138.8.2718 · DOI · Paper page
  88. Lotzova, 1987, Impaired NK cell profile in leukemia patients, Vol. 2, 29
  89. Majewski, 1987, Natural killer cell activity of peripheral blood mononuclear cells from patients with various forms of systemic scleroderma, Brit. J. Dermatol., 116, 1, 10.1111/j.1365-2133.1987.tb05784.x · DOI
  90. Maluish, 1983, Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon, J. Immunol., 131, 5030, 10.4049/jimmunol.131.1.503 · DOI
  91. Mangan, 1984, Natural killer cells suppress human erythroid stem cell proliferation in vitro, Blood, 63, 260, 10.1182/blood.V63.2.260.260 · doi:10.1182/blood.v63.2.260.260
  92. Matera, 1983, Natural killer activity and low affinity E rosettes in acute leukemia, Acta Haematol., 70, 158, 10.1159/000206716 · doi:10.1159/000206716
  93. Melder, 1989, Lymphokine-activated killer (LAK) cell cytotoxicity against HIV-infected human monocytes, FASEB J, 3, A1283
  94. Miller, 1988, Reduced natural killer cell activity in patients with systemic sclerosis, Arthritis Rheum., 31, 1515, 10.1002/art.1780311208 · DOI
  95. Minato, 1982, Studies of the functions of natural killer-interferon system in patients with Sjogren's syndrome, J. Clin. Invest., 69, 581, 10.1172/JCI110484 · doi:10.1172/jci110484
  96. Mitchell, 1984, Spontaneous and interferon resistant natural killer cell anergy in AIDS, AIDS Res., 1, 221, 10.1089/aid.1.1983.1.221 · doi:10.1089/aid.1.1983.1.221
  97. Mullbacher, 1984, An improved colorimetric assay for T cell cytotoxicity in vitro, J. Immunol. Methods, 68, 205, 10.1016/0022-1759(84)90151-0 · doi:10.1016/0022-1759(84)90151-0
  98. Nesbit-Brown, E., and Lee, J., Fluorescence-based measurement of cytolytic T cell activity. J. Immunol. Methods, in press.
  99. Newhonen, 1987, Increased number of functionally defective large granular lymphocytes in lymphoma patients, Nat. Immun. Cell Growth Regul., 6, 57
  100. Niederwieser, 1987, Rapid reappearance of large granular lymphocytes (LGL) with concomitant reconstitution of natural killer (NK) activity after human bone marrow transplantation (BMT), Brit. J. Hematol., 65, 301, 10.1111/j.1365-2141.1987.00295.x-i1 · doi:10.1111/j.1365-2141.1987.00295.x-i1
  101. Ortaldo, 1984, Heterogeneity of natural killer cells, Annu. Rev. Immunol., 2, 359, 10.1146/annurev.iy.02.040184.002043 · doi:10.1146/annurev.iy.02.040184.002043 · Paper page
  102. Ortaldo, 1986, Lymphokine-activated killer cells: Analysis of progenitors and effectors, J. Exp. Med., 164, 1193, 10.1084/jem.164.4.1193 · doi:10.1084/jem.164.4.1193
  103. Oshimi, 1982, Natural killer cell activity in untreated SLE, Ann. Rheum. Dis., 41, 417, 10.1136/ard.41.4.417 · doi:10.1136/ard.41.4.417
  104. Oshimi, 1986, Cytotoxicity of interleukin 2-activated lymphocytes for leukemia and lymphoma cells, Blood, 68, 938, 10.1182/blood.V68.4.938.938 · doi:10.1182/blood.v68.4.938.938
  105. Papa, 1988, Combined effects of chemotherapy and interleukin 2 in the therapy of mice with advanced pulmonary tumors, Cancer Res., 48, 122
  106. Pederson, 1988, Impaired release of natural killer cytotoxic factor in patients with primary Sjogren's syndrome, Clin. Exp. Immunol., 72, 299
  107. Phillips, 1987, In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin 2 LAK cell therapy, J. Clin. Oncol., 5, 1933, 10.1200/JCO.1987.5.12.1933 · DOI
  108. Pistoia, 1985, Large granular lymphocytes have a promoting activity on human peripheral blood erythroid burst-forming units, Blood, 65, 464, 10.1182/blood.V65.2.464.464 · DOI
  109. Plaeger-Marshall, 1987, Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune deficiency syndrome (AIDS), J. Clin. Immunol., 7, 16, 10.1007/BF00915420 · doi:10.1007/bf00915420
  110. Pollack, 1982, In vivo reduction of NK activity with anti-NK1 serum: Direct evaluation of NK cells in tumor clearance, Int. J. Cancer, 29, 203, 10.1002/ijc.2910290215 · DOI
  111. Pross, 1976, Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. I. The effect of malignant disease, Int. J. Cancer, 18, 593, 10.1002/ijc.2910180508 · DOI
  112. Pross, 1981, Spontaneous human lymphocyte mediated cytotoxicity against tumor target cell. IX. The quantitation of natural killer cell activity, J. Clin. Immunol., 1, 51, 10.1007/BF00915477 · DOI · Paper page
  113. Purtilo, 1981, Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological and immunopathological studies, Cancer Res., 41, 4226
  114. Roder, 1980, A new immunodeficiency disorder in humans involving NK cells, Nature (London), 284, 553, 10.1038/284553a0 · DOI · Paper page
  115. Rook, 1983, Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome, J. Clin. Invest., 72, 398, 10.1172/JCI110981 · doi:10.1172/jci110981
  116. Rooney, 1986, Natural killer cell activity following T cell depleted allogeneic bone marrow transplantation, Brit. J. Haematol., 62, 13, 10.1111/j.1365-2141.1986.tb02952.x · DOI
  117. Rosenberg, 1988, Immunotherapy of cancer using interleukin 2: Current status and future prospects, Immunol. Today, 9, 58, 10.1016/0167-5699(88)91261-3 · doi:10.1016/0167-5699(88)91261-3
  118. Rosenberg, 1987, A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin 2 or high dose interleukin 2 alone, N. Engl. J. Med., 316, 889, 10.1056/NEJM198704093161501 · DOI · Paper page
  119. Rousset, 1986, Studies of EBV-lymphoid cell interactions in two patients with the X-linked lymphoproliferative syndrome: Normal EBV-specific HLA-restricted cytotoxicity, Clin. Exp. Immunol., 63, 280
  120. Ruco, 1983, Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia, Blood, 61, 1132, 10.1182/blood.V61.6.1132.1132 · doi:10.1182/blood.v61.6.1132.1132
  121. Ruscetti, 1986, Analysis of effector mechanisms against HTLV-1 and HLTV-IIILAV infected lymphoid cells, J. Immunol., 136, 3619, 10.4049/jimmunol.136.10.3619 · doi:10.4049/jimmunol.136.10.3619
  122. Saemundsen, 1981, Epstein-Barr virus carrying lymphoma in a patient with ataxia telangiectasia, Brit. Med. J., 282, 425, 10.1136/bmj.282.6262.425 · doi:10.1136/bmj.282.6262.425
  123. Salup, 1986, Adjuvant immunotherapy of established murine renal cancer by interleukin 2 stimulated cytotoxic lymphocytes, Cancer Res., 46, 3358
  124. Santoli, 1978, Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocytes, J. Immunol., 121, 526, 10.4049/jimmunol.121.2.526 · DOI
  125. Schantz, 1986, Natural killer cell activity in head and neck cancer: A clinical assessment, JNCI, 77, 869
  126. Schantz, 1987, Multi modality therapy and distant metastasis: The impact of natural killer cell activity, Arch. Otolaryngol. Head Neck Surg., 113, 1207, 10.1001/archotol.1987.01860110073011 · DOI
  127. Schantz, 1987, Evidence for the role of natural immunity and the control of metastatic spread of head and neck cancer, Cancer Immunol. Immunother., 25, 141, 10.1007/BF00199955 · DOI
  128. Schwartz, 1959, The effect of 6-mercaptopurine on primary and secondary immune responses, J. Clin. Invest., 38, 1394, 10.1172/JCI103915 · doi:10.1172/jci103915
  129. Sibbitt, 1983, Natural killer cells in systemic lupus erythematosus: Defects in effector lytic activity and response to interferon and interferon inducers, J. Clin. Invest., 71, 1230, 10.1172/JCI110872 · doi:10.1172/jci110872
  130. Silagi, 1986, Successful immunotherapy of mouse melanoma in sarcoma with recombinant interleukin and cyclophosphamide, J. Biol. Response Modif., 5, 411
  131. Sirianni, 1988, Mechanism of defective natural killer cell activity in patients with AIDS is associated with defective distribution of tubulin, J. Immunol., 140, 2565, 10.4049/jimmunol.140.8.2565 · DOI
  132. Son, 1982, Depressed natural killer cell activity in patients with hepatocellular carcinoma: In vitro effects of interferon and levamisol, Cancer, 50, 2820, 10.1002/1097-0142(19821215)50:12<2820::AID-CNCR2820501222>3.0.CO;2-# · doi:10.1002/1097-0142(19821215)50:12<2820::aid-cncr2820501222>3.0.co;2-#
  133. Starzl, 1985, Liver stability of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy, Lancet, 1, 583
  134. Steinhauer, 1982, Effective natural cytotoxicity in patients with cancer: Normal number of effector cells but decreased recycling capacity in patients with advanced disease, J. Immunol., 129, 2255, 10.4049/jimmunol.129.5.2255 · doi:10.4049/jimmunol.129.5.2255
  135. Straus, 1985, Persisting illness in fatigue in adults with evidence of Epstein-Barr virus infection, Ann. Int. Med., 102, 7, 10.7326/0003-4819-102-1-7 · DOI · Paper page
  136. Strayer, 1984, Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidences of cancer, Cancer Res., 44, 370
  137. Strayer, 1986, Familial occurrence of breast cancer is associated with reduced natural killer cytotoxicity, Breast Cancer Res. Treat., 7, 187, 10.1007/BF01806249 · DOI
  138. Sullivan, 1980, Deficient natural killer cell activity in X-linked lymphoproliferative syndrome, Science, 210, 543, 10.1126/science.6158759 · DOI
  139. Takasugi, 1977, Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression, Cancer Res., 37, 413
  140. Takeda, 1987, Selective impairment of alpha interferon-mediated natural killer augmentation in Sjogren's syndrome: Differential effects of alpha interferon, gamma interferon and interleukin 2 on cytolytic activity, Clin. Exp. Immunol., 70, 354
  141. Tartter, 1986, Changes in peripheral T cell subsets and natural killer cytotoxicity in relation to colon rectal cancer surgery, Cancer Detect. Prev., 9, 359
  142. Thoen, 1987, Natural killer (NK) cells at inflammatory sites of patients with rheumatoid arthritis and IgM rheumatoid factor-positive polyarticular juvenile rheumatoid arthritis, Clin. Rheumatol., 6, 215, 10.1007/BF02201027 · doi:10.1007/bf02201027
  143. Tichatschek, 1988, Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer, Cancer Immunol. Immunother., 27, 278, 10.1007/BF00205452 · doi:10.1007/bf00205452
  144. Tilden, 1986, Demonstration of NK cell-mediated lysis of varicella-zoster virus (VZV)-infected cells: Characterization of the effector cells, J. Immunol., 136, 4243, 10.4049/jimmunol.136.11.4243 · DOI
  145. Timonen, 1981, Characteristics of human large granular lymphocytes and relationship to natural killer and K cells, J. Exp. Med., 153, 569, 10.1084/jem.153.3.569 · DOI · Paper page
  146. Todd, 1988, The CC11CD18 leukocyte glycoprotein deficiency, Hematol. Oncol. Clin. North Amer., 2, 13, 10.1016/S0889-8588(18)30629-4 · DOI
  147. Tonnesen, 1983, Natural killer cell activity during premedication, anesthesia, and surgery, Acta Anaesthesiol. Scand., 27, 238, 10.1111/j.1399-6576.1983.tb01943.x · DOI
  148. Trinchieri, 1984, Human natural killer cells: Biologic and pathologic aspects, Lab. Invest., 50, 489
  149. Tursz, 1982, Low natural killer cell activity in patients with malignant lymphoma, Cancer, 50, 2333, 10.1002/1097-0142(19821201)50:11<2333::AID-CNCR2820501119>3.0.CO;2-W · doi:10.1002/1097-0142(19821201)50:11<2333::aid-cncr2820501119>3.0.co;2-w
  150. Welsh, 1986, Regulation of virus infections by natural killer cells, Nat. Immun. Cell Growth Regul., 5, 169
  151. West, 1987, Constant-infusion recombinant interleukin 2 in adoptive immunotherapy of advanced cancer, N. Engl. J. Med., 316, 898, 10.1056/NEJM198704093161502 · doi:10.1056/nejm198704093161502
  152. Ziegler, 1981, Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia, Int. J. Cancer, 27, 321, 10.1002/ijc.2910270310 · doi:10.1002/ijc.2910270310
  153. Zielinski, 1986, Impaired primary, but not secondary, immune response in breast cancer patients under adjuvant chemotherapy, Cancer, 58, 1648, 10.1002/1097-0142(19861015)58:8<1648::AID-CNCR2820580812>3.0.CO;2-E · doi:10.1002/1097-0142(19861015)58:8<1648::aid-cncr2820580812>3.0.co;2-e

Cited by

See all 217

Metadata

Authors
Whiteside, T. L., & Herberman, R. B.
Venue
Clinical Immunology and Immunopathology
Publisher
Elsevier BV
Published
1989-10
Volume
53
Issue
1
Pages
1-23
ISSN
0090-1229 (ISSN-L)
OpenAlex
W2074846327
Cited by
217
References
0
FWCI
5.37
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of natural killer cells in human disease. https://app.cochat.ai/papers/10.1016/0090-1229(89)90096-2
The paper
Whiteside, T. L., & Herberman, R. B. (1989). The role of natural killer cells in human disease. Clinical Immunology and Immunopathology. https://doi.org/10.1016/0090-1229(89)90096-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.